W
Wave Life Sciences Ltd
WVE
6.16000
USD
-0.46
(-6.95%)
مغلق
حجم التداول
36,349
الربح لكل سهم
0
العائد الربحي
0
P/E
-26
حجم السوق
2,190,588,315
الأخبار
العنوان: Wave Life Sciences Ltd
القطاع: Healthcare
الصناعة: Biotechnology
WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.